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Abstract
Background: Ruptures of the anterior cruciate ligament (ACL) are common injuries to the knee joint. Arthroscopic ACL
replacement by autologous tendon grafts has established itself as a standard of care.
Data from both experimental and observational studies suggest that surgical reconstruction does not fully restore knee stability.
Persisting anterior laxity may lead to recurrent episodes of giving-way and cartilage damage. This might at least in part depend
on the method of graft fixation in the bony tunnels. Whereas resorbable screws are easy to handle, pins may better preserve
graft tension. The objective of this study is to determine whether pinning of ACL grafts reduces residual anterior laxity six
months after surgery as compared to screw fixation.
Design/ Methods: SPOT is a randomised, controlled, patient and investigator blinded trial conducted at a single academic
institution. Eligible patients are scheduled to arthroscopic ACL repair with triple-stranded hamstring grafts, conducted by a
single, experienced surgeon. Intraoperatively, subjects willing to engage in this study will be randomised to transplant tethering
with either resorbable screws or resorbable pins. No other changes apply to locally established treatment protocols. Patients
and clinical investigators will remain blinded to the assigned fixation method until the six-month follow-up examination.
The primary outcome is the side-to-side (repaired to healthy knee) difference in anterior translation as measured by the KT-
1000 arthrometer at a defined load (89 N) six months after surgery. A sample size of 54 patients will yield a power of 80% to
detect a difference of 1.0 mm ± standard deviation 1.2 mm at a two-sided alpha of 5% with a t-test for independent samples.
Secondary outcomes (generic and disease-specific measures of quality of life, magnetic resonance imaging morphology of
transplants and devices) will be handled in an exploratory fashion.
Conclusion: SPOT aims at showing a reduction in anterior knee laxity after fixing ACL grafts by pins compared to screws.
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Background
Anterior cruciate ligament (ACL) rupture belongs to the
most common musculoskeletal injuries in the western
world. In the United States, 100,000 new cases occur each
year, with 10% of all injuries leading to occupational dis-
ability [1]. In Germany, the prevalence of torn ACL among
subjects between 20 and 35 years averages 0.4%. In the
general population, the yearly incidence of ACL rupture
reaches 32/100,000, but peaks to 70/100,000 in athletes
[2].
An ACL deficient knee is at risk of developing secondary
damage to the cartilage and is liable to undergo progres-
sive intra-articular worsening. Roughly half of all acute
ACL disruptions attend meniscus damage. Arthroscopic
reconstruction surgery by autologous grafting emerged as
the therapy of choice. Predictions call for 175,000 ACL
replacements performed yearly in the United States. In
Germany, around 50,000 patients undergo ACL repair
each year.
Selecting the ideal graft remains an issue of debate. Rand-
omized controlled trials suggest a lower degree of persist-
ent laxity with bone-patellar-tendon-bone (BPTB)
comparing with two-, three- or four-bundle hamstring
(that is, semitendinosus and gracilis tendon) transplants
(HT).
However, the biomechanical advantage does not frame
higher patient satisfaction, or differences in scoring after
long-term follow-up [3]. In contrast, harvesting BPTB
grafts often produces notable donor site morbidity, and
refractory kneeling pain [4,5].
Available data from randomized, quasi-randomized and
uncontrolled trials signal a weighted mean difference of
2.28 mm (95% confidence interval [CI] 1.83 – 2.73 mm)
in anterior laxity between the injured and healthy knee
with HT reconstruction (see Figure 1) [3,6-16].
Many features contribute to an unsatisfactory or failed
ACL replacement, for example, imprecise tunnel position-
ing, the presence of degenerative changes, or the onset of
arthrofibrosis.
The choice of tibial graft fixation affects later stability. The
intact ACL has a tensile strength around 2200 N. To avoid
loosening, the graft must be fixed under firm traction
(around 40 N), with the knee in a smoothly flexed posi-
tion. A common way to anchor the tibial end of the graft
is by titanium or biodegradable interference screws, for
example, the BioCryl® (DePuy Mitek) screw that contains
both resorbable poly-L-lactid and osteoconductive trical-
cium phosphate (see Figure 2).
However, in a recent biomechanical study, extracortical
fixation devices like the EndoButton® (Smith & Nephew)
or RigidFix® (DePuy Mitek) provided better strength than
did the interference screws [17]. The possible advantage of
RigidFix® over other tethering methods is a splicing of
strands, tightening the contact between the tendon surface
and the bony tunnel over the entire graft circumference
(see Figure 3).
Methods/ Design
Objectives
The present study aims at comparing later laxity in sub-
jects undergoing arthroscopic anterior cruciate ligament
replacement with either RigidFix®  pinning or BioCryl®
screwing of HT grafts. Both implants are CE approved, and
were introduced to ACL-repair in Germany in 2002.
We have secondary objectives in imagining graft incorpo-
ration by MRI-scanning, functional results, residual pain,
resumption of occupational and leisure activity, and qual-
ity of life by generic and disease-specific questionnaires.
Primary endpoint
We pose the primary hypothesis that the RigidFix® system
preserves graft tension gained during surgery, and leads to
lower KT-1000 arthrometer side-to-side differences than
the BioCryl® screw after six months of follow-up.
Specifically, we will test the hypothesis that RigidFix®
decreases the average difference gained with interference
screws by 1.0 ± standard deviation 1.2 mm. The investiga-
tors consider this difference clinically sound, important,
and measurable by KT-1000 arthrometer testing. Twenty-
four subjects a treatment arm will allow for detecting this
difference with an 80% chance at a two-sided alpha-level
of 5%. Assuming a drop-out rate of 10%, 54 patients will
be enrolled in this study.
Secondary endpoints
As secondary endpoints, we consider functional outcomes
by means of the Lysholm scale, the Tegner score, and the
International Knee Documentation Committee evalua-
tion form (IKDC) in its German translation, 2000 revision
[18]. Besides disease-specific items, this questionnaire
also contains the Short-Form 36 (SF-36) generic health
assessment tool. The noted instruments have proven reli-
ability, validity, and responsiveness for use in clinical
research.
Confirmatory testing will apply for the primary endpoint
only. All secondary endpoints will be addressed in an
exploratory fashion.BMC Surgery 2005, 5:1 http://www.biomedcentral.com/1471-2482/5/1
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Design
SPOT is a patient and investigator blinded, randomised
controlled trial conducted at a single academic institution.
Randomisation is carried out in the operating theatre
shortly before transplant fixation, with random codes
drawn from sealed envelopes. We use block-randomisa-
tion with five subjects a block following a computer-gen-
erated random list [19].
Inclusion criteria
Men and women (providing that they are not pregnant)
being at least 18 years old are recruited to this trial. Sub-
jects may engage in this study if they
- faced a first one-sided total or subtotal rupture of the
anterior cruciate ligament, proven either by arthroscopy
or MRI-scanning
- had met an acute knee distorsion event likely to have
caused the index injury at least six weeks before scheduled
repair
- have been physically examined in the ambulatory of the
study hospital before assigning an admission date, and
were screened and considered suitable to enter this trial by
one of the investigators
Persisting instability following ACL repair with HT autografts (KT-1000 measurements) Figure 1
Persisting instability following ACL repair with HT autografts (KT-1000 measurements). Individual study results were weighted 
by their inverse variance to derive a common point estimate with 95% confidence interval (diamond).
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Also, patients must be able to give voluntary written
informed consent, and to comply with the post operative
follow up regime
Exclusion criteria
We exclude patients
- with related lower limb fractures
- with active infection affecting the limb subject to needed
treatment
- who have previously took part in this investigation or
who are taking part in another clinical investigation
- with contraindications for MRI-scanning (that is, large
indwelling orthopaedic implants made of metals others
than titanium, or pacemakers)
Ethical considerations
This protocol and all accompanying documents were
approved by the local Institutional Review Board (IRB).
According to IRB recommendations and requirements,
information leaflets explicitly note that "a benefit from
participation in this trial cannot be guaranteed."
We will stress the principle of randomisation as "treat-
ment assignment by chance, without the possibility of the
Appearance of the BioCryl® screws (left, courtesy of DePuy Mitek), and their positioning (right) Figure 2
Appearance of the BioCryl® screws (left, courtesy of DePuy Mitek), and their positioning (right).BMC Surgery 2005, 5:1 http://www.biomedcentral.com/1471-2482/5/1
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investigator, other health care professionals involved in
this study, or the patient influencing the choice of treat-
ment." We also tell patients that, as long as they keep
agreement in participation, they will not know their
assigned treatment until the six-month follow-up visit.
We will notify the IRB of any significant changes to the
protocol. Also, we will notify the IRB within ten working
days of the discovery of any severe adverse events which
occur during this investigation.
Confidentiality of subject data will always be maintained.
Subject anonymity will be guaranteed and all documenta-
tion about a subject (including radiographs) will be kept
in secure location.
This investigation strictly adheres to the relevant articles of
the Declaration of Helsinki as adopted by the 18th World
Medical Assembly in 1964 and its later revisions, as well
as to principles of GCP, developed within the Expert
Working Group (Efficacy) of the International Conference
on Harmonisation of Technical Requirements for Regis-
tration of Pharmaceuticals for Human Use (ICH).
Surgery and rehabilitation
All devices and instrumentations used in this clinical
investigation bear the CE mark. They belong to the regular
implants used for ACL repair at the study hospital since
2002. Except different graft anchoring, similar treatments
apply to patients in both study groups. All participants
undergo internationally accepted surgically procedures by
Left: Positioning of RigidFix® pins Figure 3
Left: Positioning of RigidFix® pins. Right: splicing of graft bundles leading to close adherence to the surrounding bone.BMC Surgery 2005, 5:1 http://www.biomedcentral.com/1471-2482/5/1
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a single surgeon (D.C.) with extensive experience in ACL
repair using both the BioCryl® screw and RigidFix® cross
pins. Also, postoperative care and rehabilitation programs
do not differ from those employed outside a clinical trial.
All repairs are carried out under general anaesthesia, with
the patient in a supine position. Perioperative antibiotic
prophylaxis comprises 2 g of cefotiam. Patients receive 40
mg of enoxaparin daily for prophylaxis of thromboem-
bolic events until full weight bearing.
The knee joint is accessed through two to three standard
portals. Meniscal injuries are addressed with partial resec-
tion or repair.
Hamstring tendons are harvested via a small incision over
the insertion of the pes anserinus at the anterior medial
tibia by a closed tendon stripper, and prepared as triple-
stranded grafts.
Tibial and femoral tunnels are drilled to approximate graft
thickness (usually 8 to 9 mm) with the use of a guiding
wire. Grafts are fixed with the knee in 30° flexion to
achieve firm tension.
Postoperatively, the knee is stabilized for three days by a
zero-degree splint. Afterwards, flexion is limited to 90° by
a Secutec® orthosis for six weeks. Patients are allowed par-
tial weight bearing with walking crutches. Subjects are pre-
scribed intense physical therapy for motion exercise, and
to strengthen thigh muscles. Normally, full range of
motion and weight bearing is achieved until week 12 after
surgery.
Patients in the experimental group have their grafts
secured by tibial and femoral RigidFix® pinning. Patient in
the control group receive tibial and femoral BioCryl®
screws.
Baseline assessment
Each subject considered eligible for entry into this investi-
gation has the following information and procedures
recorded at the pre-investigational examination:
- Demographic details including date of birth and gender
- Medical history, coexisting diseases, and accompanying
medication
- Physical examination, including circumferential meas-
urement of both legs at defined landmarks, Lachman and
pivot shift tests, KT-1000 arthrometer objectifying of
instability, one-legged hop test, Lysholm, Tegner, and
IKDC scores, knee and kneeling pain measured by visual
analogue scales
- Radiographic examination, including a conventional
roentgenogram of the injured knee in anteroposterior and
lateral projection, and a preoperative MRI scan according
to local standards
Intraoperative assessments
During surgery, we record procedure details in the elec-
tronic CRF. We assess the duration of surgery (from cut to
skin closure), and operating theatre time (from induction
of anaesthesia to arrival at the recovery room). A clinical
knee examination is performed and documented with the
subjects under general anaesthesia and relaxation.
Arthroscopy findings (accompanying injuries to or degen-
erative changes of the cruciate or collateral ligaments,
menisci, or cartilage) are recorded by video and/ or hard
copy images.
We document eventual blood loss, and any other adverse
event occurring during surgery.
The responsible surgeon judges the handling of implants
and his overall satisfaction with the intraoperative result
using five-point Likert scales. We detail any problems or
complications on an Adverse Events form.
Follow-up assessments
Patients are appointed outpatient visits as part of the clin-
ical investigation at 3, 6, and 12 months postoperatively.
For study purposes, except quality of life measurements,
patients do not undergo any diagnostic or other proce-
dure not belonging to the common repertoire of assess-
ments carried out after ACL repair. Specifically, we avoid
invasive procedures, blood sampling, or imaging tests
exposing subjects to radiation or contrast agents. The
investigators consider the possible burden caused by extra
clinical tests negligible.
We assess the following items at the scheduled visits:
Three months postoperatively
- Physical examination, including circumferential meas-
urement of both legs at defined landmarks, Lachman and
pivot shift tests, KT-1000 arthrometer objectifying of
instability, one-legged hop test, Lysholm, Tegner, and
IKDC scores, knee and kneeling pain measured by visual
analogue scales
- Any complications or complaints raised by the patient,
GP/ ambulatory surgeon, or Clinical Investigators
- Resumption of work
- MRI scan according to local standardsBMC Surgery 2005, 5:1 http://www.biomedcentral.com/1471-2482/5/1
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Six months postoperatively
- Physical examination, including circumferential meas-
urement of both legs at defined landmarks, Lachman and
pivot shift tests, KT-1000 arthrometer objectifying of
instability, one-legged hop test, Lysholm, Tegner, and
IKDC scores, knee and kneeling pain measured by visual
analogue scales
- Any complications or complaints raised by the patient,
GP/ ambulatory surgeon, or Clinical Investigators
- Resumption of work and leisure activities
- MRI scan according to local standards
Patients and Investigators responsible for follow-up
examinations may learn about the assigned treatment
after completing the six-month CRF.
Twelve months postoperatively
- Physical examination, including circumferential meas-
urement of both legs at defined landmarks, Lachman and
pivot shift tests, KT-1000 arthrometer objectifying of
instability, one-legged hop test, Lysholm, Tegner, and
IKDC scores, knee and kneeling pain measured by visual
analogue scales
- Any complications or complaints raised by the patient,
GP/ ambulatory surgeon, or Clinical Investigators
- Resumption of work and leisure activities
- MRI scan according to local standards
MRI studies
Radiological evaluation comprises
- Tunnel widening
- Impingement
- Transplant sufficiency, morphology of transitional areas
and tendon-bone-interfaces
- Degree of degradation of screws and pins
- Degree of inflammation (synovitis) and effusion
- Presence or progression of arthrofibrosis
- Changes in cartilage and meniscal morphology
Physical examination
Before physical examination, both knees are prepared by
applying opaque dressings to hide scars and to blind the
examining doctors for the managed side.
Examination is performed independently by two of three
board-certified surgeons (D.S., K.B., V.T.) who had not
operated on any of the patients in the study. The respon-
sible surgeon (D.C.) conducts a third clinical examination
after completion of the case report forms. We document
his examination findings separately and consider them as
the diagnostic reference standard. We assess both interob-
server agreement by kappa statistics and the accuracy of
measurements taken by independent observers compar-
ing with those of the responsible surgeon.
KT-1000 arthrometer testing
Objective translation measurements comprise a defined
load (89 N). We measure the anterior translation of the
injured and healthy side (in mm), as well as the difference
between both knees.
Safety assessment and reporting of adverse event
We define an adverse event as 'any undesirable clinical
instance in a subject whether it is considered treatment
related or not'. In addition, an adverse device effect, unde-
sirable side effect, is defined as 'a device related adverse
event'.
A record of all adverse events, including details of the
nature, onset, duration, severity, relationship to the
device, relationship to the operative procedure and out-
come, will be made on the relevant section of the subject's
CRF. The subject will be questioned about any adverse
event at each later follow-up assessment visit.
An adverse event or an adverse device effect may be mild,
moderate or severe and are usually unexpected.
A severe adverse event or adverse device effect is defined as
any experience that
- is fatal or life-threatening
- is permanently disabling
- needs or prolongs in-patient hospitalization because of
a potential disability, danger to life or forces an
intervention
All severe adverse events or adverse effects which occur
during this investigation must be and will be reported
immediately by telephone or facsimile toBMC Surgery 2005, 5:1 http://www.biomedcentral.com/1471-2482/5/1
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Bundesinstitut für Arzneimittel und Medizinprodukte,
Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Phone:
++49 30 228 207 30, Fax: ++49 30 228 207 5207
Data management
For data collection, we set up a Microsoft XP Professional
Access® Database, run on a mobile computer separately
from the hospital documentation and the intranet. Data
collection and storage comply with orders fixed by the
data safety board of the Unfallkrankenhaus Berlin, and
follow German laws for data safeguard and protection
(Bundesgesetz über den Schutz personenbezogener Daten [Dat-
enschutzgesetz 2000 – DSG 2000], 17. August 1999,
BGBl. I Nr. 1999/165). We ensure data storage for five
years.
For study documentation, we assign patients an identifica-
tion number. Electronic sources do not contain names or
addresses of participants. Linking lists are stored in a study
folder with copies of adverse events forms.
Since this study runs at a single centre, we do not appoint
an external monitor for data handling and management.
We regularly (at least twice a month) check datasets for
consistency, completeness and plausibility.
Statistical analysis
We will conduct all analyses following the intention to
treat principle (that is, patients will be evaluated as
randomized).
We will express measurements as means, medians or pro-
portions with their proper distribution indices (that is,
standard deviations, ranges, and interquartile ranges). In
case of skewed distributions, normalizing will be achieved
by logarithmic transformation, where necessary.
As pointed out earlier, we will address only the primary
hypothesis in a confirmatory fashion, whereas all other
results will be evaluated in a plain exploratory intent.
We will employ the student's t-test for independent sam-
ples to test for the difference in anterior laxity between
both fixation methods at six months of follow-up.
For secondary endpoint analysis, we will calculate cross
tables, 95% confidence intervals for normally or binomi-
ally distributed data, and differences in means, propor-
tions, and ratios. In case of obvious benefits or harms with
either device in a certain subgroup of patients, we will use
stratified analyses (for example, according to Mantel-
Haenszel).
Where statistically and/ or clinically sound, we will con-
sider linear and logistic regression analyses, or more
sophisticated regression models for correlated data (for
example, generalized estimating equations). We will,
however, respect the small sample size of this study, and
limit statistical analyses to the necessary minimum.
In case of missing data, we will use both a last observation
carried forward approach, and imputation methods by
regression or semi-Bayesian modelling. Separate analyses
will be performed for raw and modelled data.
Discussion
After ACL repair, most patients rarely recognize slightly
weakened anterior knee stability in everyday life. How-
ever, subjects with a high recreational and sporting activ-
ity and physically strenuous professions often suffer from
recurrent events of giving-way, especially on hastened
movements. This poses a high risk for secondary knee
injury. Of note, muscular training cannot compensate for
residual laxity, outbalancing the anticipated benefit from
surgical repair.
Thus, attempts to optimize the surgical technique may be
valuable. Currently, surgeons performing ACL
reconstruction use screws, pins, buttons, and cramps for
graft fixation because of individual preference, or institu-
tional orders. The latter are chiefly driven by cost consid-
erations. For example, the purchase price of a RigidFix®
tray is ten times higher than that of BioCryl® screws. Obvi-
ously, the more expensive implant must prove a distinct
clinical advantage over the common one to justify its fur-
ther use. Unfortunately, there is lack of robust evidence on
the effectiveness of either fixation method beyond labora-
tory and animal experiments.
Although conceptually impressive, there is no compara-
tive study that proved a clinically measurable advantage of
RigidFix® over screws. The investigators consider the equi-
poise principle fulfilled, since it is unclear whether screw
or pins lead to better long-term stability, or show any
measurable differences at all. We hope that the results
from this pragmatic study can clarify this issue.
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